India CRO Market Size Worth USD 979.8 Million by 2030 at 7.50% CAGR – Report by Market Research Future (MRFR)

India CRO Market Trends and Insights by Services Type (Clinical trials, Product Development, Process Development, Post-Marketing Surveillance, Quality Monitoring and Others); by Therapeutic Application (Oncology, Cardiovascular, Neurology, Nephrology and Urology, and Others) and by End Users (Pharmaceutical/biopharmaceutical Companies, Medical devices Companies and Academic Institutes), Competitive Market Growth, Size, Share and Forecast to 2030

New York, New York, UNITED STATES

New York, USA, May 03, 2023 (GLOBE NEWSWIRE) -- India CRO Market Overview

According to a Comprehensive Research Report by Market Research Future (MRFR), “India CRO Market Information by Services Type, Therapeutic Application and End Users- Forecast till 2030”, the market is expected to reach USD 979.8 Million by 2030 at 7.50% CAGR during the forecast period 2022-2030.

Market Scope:

A contract research organization's services may be required by pharmaceutical, biotechnology, and healthcare corporations (CRO). Clinical research, process and product development, quality control, post-marketing surveillance, and other services are among the ones offered. CROs also provide management services for clinical trials and pharmacovigilance. The Indian government has eliminated a number of elements from clinical trial regulations that required the sponsor to compensate the patient's family up to 60% of the total cost in the event of death or permanent impairment during a clinical study. Pharmaceutical firms also view India as a venue for local clinical trials where they may benefit more from marketing the medication once it has been authorized in Europe, the United Kingdom, the United States, Australia, and other countries.

Get Free Sample PDF Brochure @

Report Scope:

Report AttributeDetails
Market Size in 2030USD 979.8 Million
Base Year2021
Forecast Period2022-2030
Historical Data2020
Forecast UnitsValue (USD Million)
Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Coveredby Services Type, Therapeutic Application and End Users
Geographies CoveredNorth America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market DriversRising demand for new solutions in the healthcare business
Technological developments and Increased investment from both international and domestic market players

India CRO Market Competitive Dynamics:

The India CRO market major Players are:

  • Quintiles IMS Holdings, Inc
  • Syngene, Pharmaceutical Product Development, LLC.
  • Siro Clinpharm, Clininvent Research Pvt. Ltd.
  • VIMTA, Bilcare Limited
  • Aizant Drug Research Solutions Private Limited
  • Piramal Pharma Solutions
  • Synapse Labs Pvt Limited,
  • Eurofins Scientific
  • Laurus Labs.
  • Neuland Laboratories Ltd
  • PAREXEL International Corporation

India CRO Market Trends

Market Drivers

The sector is significantly influenced by the existence of diverse India CRO climate testing conditions, the implementation of international standards, and intellectual property rights. The presence of a sizable patient pool, a sizable number of hospitals, skilled and readily accessible human resources, and low operating costs as a result of affordable human resources are other variables that aid the market in achieving its goal during the projected period. India has swiftly risen to the top of the list of preferred locations for clinical trials as a result of its vast and diverse patient population, rapidly developing healthcare industry, highly skilled medical professionals, and cost-competitiveness. Also, it is anticipated that during the projection period, increasing investment from local and international market participants would fuel market development. In addition, expanding research industries like diagnostic research are probably fueling the expansion of the Indian CRO market.

The market also benefits from regulatory agencies' efforts to establish a supportive environment for research in India, such as those of the Director Controller General of India (DCGI), Indian Council of Medical Research (ICMR), Directorate General of Foreign Trade (DGFT), and Department of Biotechnology (DBT). The clinical trial market is largely driven by increased healthcare industry need for innovative solutions, partnerships between top Indian CRO organizations and pharma, biotech, and medical device companies, and technological advancements. Major factors influencing market expansion have been recognized as the high need for clinical trials in developing nations, the pharmaceutical industry's high R&D spending, the rising incidence of illnesses, the focus on rare diseases and the abundance of orphan medications in R&D.

Market Limitations

Commercial constraints, a lack of cooperation between academia and business, and rising concern about security—particularly the protection of data and patients—are contributing to these issues. Growth may be constrained by drug research's escalating cost. Drugmakers and sponsors are under pressure to make up income lost as a result of generic competition, rising patent expiration rates, the number of biologics research alliances, and rising R&D costs, all of which have increased the cost and complexity of drug development. The need for outsourcing research activities has also increased due to the strain on India's CRO market participants to meet rigorous deadlines.

COVID-19 Analysis:

India experienced a similar catastrophe as the rest of the world as a result of the COVID-19 pandemic. Because to variables including supply chain disruption and the temporary suspension of industrial facilities, the early phase of the pandemic caused a pause in research and development efforts across the nation, which presented challenges for clinical research. Furthermore, the lockdown's implementation has led to a decline in the number of patient studies done across the nation. The pandemic has had a significant impact on the CRO market in India. The development of additional vaccines and medications has been significantly influenced by the global endeavor to produce a coronavirus vaccine. 30% of all studies in the United States were COVID-19 vaccines and treatments at the height of the pandemic.

Browse In-depth Market Research Report (70 Pages) on India CRO:

India CRO Market Segmentation:

By Services Type

Throughout the projection period, the clinical trials segment is expected to experience a significant CAGR. The incidence of major diseases is expected to increase, there will be a desire for new, creative treatment alternatives, and there will be a large burden of chronic diseases in the nation.

By Therapeutic Application

Throughout the projection period, the oncology section is expected to increase at the quickest rate after holding the biggest revenue share in the previous two years. This is explained by the rising incidence of cancer in the nation and the rising demand for cutting-edge medical technology and cancer therapies.

By End Users

During the course of the assessment period, the pharmaceutical and biopharmaceutical businesses sector is anticipated to lead the market.

Buy Now:

India CRO Market Regional Analysis:

The healthcare industry in India is divided into many regions and states. A sizeable share of the Indian CRO market is located in south and western India. The CRO businesses in India have lately relocated to the north, nevertheless. The Director Controller General of India (DCGI) office, the Indian Council of Medical Research (ICMR), the Directorate General of Foreign Trade (DGFT), and the Department of Biotechnology (DBT), among others, have combined their regulatory authority as one of the reasons for this move. Moreover, North India's costs are lower and its genetic diversity is greater.

Discover more research Reports on Healthcare Industry by Market Research Future:

Preclinical CRO Market: Information By Service (Toxicology Testing, Bioanalysis and Drug Metabolism and Pharmacokinetics (DMPK) Studies), Application (Oncology, Central Nervous System (CNS) Disorders, Cardiovascular Diseases, Immunological Disorders, Respiratory Diseases, Infectious Diseases, Diabetes), End User (Pharmaceutical and Biopharmaceutical Industries, Medical Device Companies and Academic Institutes) - Forecast till 2030

Clinical trial management system market Research Report Information By Type (Enterprise CTMS and On-Site CTMS), Delivery Model (Web-Based [Hosted CTMS], Licensed Enterprise, Cloud-Based CTMS [SaaS]), Component (Software, Service, and Hardware), End-User (Pharmaceutical and Biopharmaceutical Companies, Medical Device Manufacturers, Contract Research Organizations, and others), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2030

Contract Research Organization (CRO) Market Research Report: Information By Type (Drug Discovery, Clinical Development), By Clinical trial (Preclinical Trials, Phase I, Phase II, Phase III, Phase IV, Others), By End User (Academic institutes, Pharmaceutical companies, Medical service companies) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter


Contact Data